Beneficient (BENF) Cash & Equivalents (2022 - 2026)

Beneficient has reported Cash & Equivalents for 5 years, with the latest figure at $2.5 million in Q1 2026.

• Quarterly Cash & Equivalents rose 85.74% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 85.74% YoY) and the FY2026 annual result came in at $2.5 million, up 85.74% from the prior year.
• Cash & Equivalents eased to $2.5 million in Q1 2026 per BENF's latest filing, from $7.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $70.6 million in Q1 2022 and troughed at $1.3 million in Q1 2025.
• A 5-year average of $10.1 million and a median of $4.7 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents sank 87.64% in 2023, then soared 92.68% in 2025.
• Over 5 years, Cash & Equivalents stood at $70.6 million in 2022, then slumped by 84.13% to $11.2 million in 2023, then sank by 63.39% to $4.1 million in 2024, then jumped by 92.68% to $7.9 million in 2025, then tumbled by 68.35% to $2.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $2.5 million, $7.9 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.